Search Results - Eveline Barbieri

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo

    Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo by Zaowen Chen, Yunfu Lin, Eveline Barbieri, Sue Burlingame, John Hicks, Andrew D. Ludwig, Jason M. Shohet

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death

    MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death by Eveline Barbieri, Parth S. Mehta, Zaowen Chen, Linna Zhang, Andrew Slack, Stacey L. Berg, Jason M. Shohet

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

    Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma by Agarwal, Saurabh, Milazzo, Giorgio, Rajapakshe, Kimal, Bernardi, Ronald, Chen, Zaowen, Eveline, Barbieri, Koster, Jan, Perini, Giovanni, Coarfa, Cristian, Shohet, Jason M.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma

    The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma by Anna Lakoma, Eveline Barbieri, Saurabh Agarwal, Jeremy R. Jackson, Z Chen, Yong Ho Kim, Matthew C. McVay, Jason M. Shohet, Eugene S. Kim

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma

    A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma by Jason M. Shohet, Rajib Ghosh, Cristian Coarfa, Andrew D. Ludwig, Ashley Benham, Zaowen Chen, Danielle Patterson, Eveline Barbieri, Pieter Mestdagh, Denae N. Sikorski, Aleksandar Milosavljevic, Eugene S. Kim, Preethi H. Gunaratne

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

    Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma by Eveline Barbieri, Katleen De Preter, Mario Capasso, Zaowen Chen, Danielle M. Hsu, Gian Paolo Tonini, Steve Lefever, John Hicks, Rogier Versteeg, Andrea Pession, Frank Speleman, Eugene S. Kim, Jason M. Shohet

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

    G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic by Danielle M. Hsu, Saurabh Agarwal, Ashley Benham, Cristian Coarfa, Denae N. Trahan, Zaowen Chen, Paris N. Stowers, Amy N. Courtney, Anna Lakoma, Eveline Barbieri, Leonid S. Metelitsa, Preethi H. Gunaratne, Eugene S. Kim, Jason M. Shohet

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Restoration of the molecular clock is tumor suppressive in neuroblastoma

    Restoration of the molecular clock is tumor suppressive in neuroblastoma by Myrthala Moreno‐Smith, Giorgio Milazzo, Ling Tao, Baharan Fekry, Bokai Zhu, Mahmoud A. Mohammad, Simone Di Giacomo, Roshan M. Borkar, Karthik Reddy Kami Reddy, Mario Capasso, Sanjeev A. Vasudevan, Pavel Sumazin, John Hicks, Nagireddy Putluri, Giovanni Perini, Kristin Eckel‐Mahan, Thomas P. Burris, Eveline Barbieri

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma

    MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma by Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, Myrthala Moreno‐Smith, Tajhal D. Patel, Barry Zorman, Andrew Badachhape, Blanca E. Hernandez, Amber B. Wolf, Zihua Zeng, Jennifer H. Foster, Sara Aloisi, Pavel Sumazin, Youli Zu, John Hicks, Ketan B. Ghaghada, Nagireddy Putluri, Giovanni Perini, Cristian Coarfa, Eveline Barbieri

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: